Logo do repositório
 

Pleiotropic Effects of Nitric Oxide on SARS-CoV-2 Infections

dc.contributor.authorTerroni, Barbara [UNESP]
dc.contributor.authorLopes, Juliana Romano [UNESP]
dc.contributor.authorChin, Chung Man [UNESP]
dc.contributor.authorDos Santos, Jean Leandro [UNESP]
dc.contributor.institutionUniversidade Estadual Paulista (UNESP)
dc.contributor.institutionUnion of the College of the Great Lakes (UNILAGO)
dc.date.accessioned2023-07-29T16:05:40Z
dc.date.available2023-07-29T16:05:40Z
dc.date.issued2021-01-01
dc.description.abstractInfection by β-coronavirus SARS-CoV-2 (Severe Acute Respiratory Syndrome Coron-avirus-2) alters the homeostasis of the vascular endothelium, promoting an inflammatory state which causes damage and favors the prothrombotic state. The direct viral cytotoxicity induced by the SARS-CoV-2 leads to endothelial cell death; thus, altering the vessel functions. Moreover, SARS-CoV infection induces endothelial dysfunction (ED) and reduces the levels of nitric oxide (NO); thus, aggravating the vascular injuries, which promotes thrombotic events due to an altera-tion in the homeostasis. NO is a pleiotropic molecule that induces vasodilation, regulates the immune response, inhibits platelet aggregation, and decreases the cellular adhesion to vascular en-dothelium. Moreover, NO acts directly against invasive agents, exhibiting antibacterial, antiviral, and antifungal activity. High levels of NO result in an increase in the ED, causing an inflammatory amplification that aggravates the disease through undesirable positive feedback. The objective of this review was to present and discuss the involvement of NO on ED in SARS-CoV-2 infections. This review may also highlight new perspectives for therapeutic interventions through the supple-mentation of exogenous NO. The maintenance of homeostatic NO levels could represent a useful approach in the prevention of coronavirus-induced ED.en
dc.description.affiliationSão Paulo State University (UNESP) School of Pharmaceutical Sciences, São Paulo
dc.description.affiliationAdvanced Research Center in Medicine School of Medicine Union of the College of the Great Lakes (UNILAGO), São Paulo
dc.description.affiliationUnespSão Paulo State University (UNESP) School of Pharmaceutical Sciences, São Paulo
dc.description.sponsorshipCoordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)
dc.description.sponsorshipFundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)
dc.description.sponsorshipConselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)
dc.description.sponsorshipIdCAPES: 001
dc.description.sponsorshipIdFAPESP: 2018/11079-0
dc.description.sponsorshipIdCNPq: 304731/2017-0
dc.description.sponsorshipIdCNPq: 313435/2019-7
dc.identifierhttp://dx.doi.org/10.2174/2666796701999201230121515
dc.identifier.citationCoronaviruses, v. 2, n. 9, 2021.
dc.identifier.doi10.2174/2666796701999201230121515
dc.identifier.issn2666-7975
dc.identifier.issn2666-7967
dc.identifier.scopus2-s2.0-85148026753
dc.identifier.urihttp://hdl.handle.net/11449/249656
dc.language.isoeng
dc.relation.ispartofCoronaviruses
dc.sourceScopus
dc.subjectCOVID-19
dc.subjectendothelium dysfunction
dc.subjectinhaled NO
dc.subjectnitric oxide
dc.subjectNO donors
dc.subjectSARS-COV-2
dc.titlePleiotropic Effects of Nitric Oxide on SARS-CoV-2 Infectionsen
dc.typeArtigopt
dspace.entity.typePublication
relation.isDepartmentOfPublicatione214da1b-9929-4ae9-b8fd-655e9bfeda4b
relation.isDepartmentOfPublication.latestForDiscoverye214da1b-9929-4ae9-b8fd-655e9bfeda4b
unesp.departmentFármacos e Medicamentos - FCFpt

Arquivos